Germline BRCA1 mutations significantly co-occurred with somatic TP53 mutations at both the pan-cancer level (FDR = 1.0 × 10−6, Figure 3A) and within breast cancer (FDR = 6.2 × 10−4, Figure 3B). This evidence concerns the gene BRCA1 and breast cancer.